See more : Actelis Networks, Inc. (ASNS) Income Statement Analysis – Financial Results
Complete financial analysis of Beijing Bohui Innovation Biotechnology Group Co., Ltd. (300318.SZ) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Beijing Bohui Innovation Biotechnology Group Co., Ltd., a leading company in the Medical – Devices industry within the Healthcare sector.
- Delta Oil & Gas, Inc. (DLTA) Income Statement Analysis – Financial Results
- Aurizon Holdings Limited (QRNNF) Income Statement Analysis – Financial Results
- Precision Electronics Limited (PRECISIO.BO) Income Statement Analysis – Financial Results
- Daniels Corporate Advisory Company, Inc. (DCAC) Income Statement Analysis – Financial Results
- Eclat Textile Co., Ltd. (1476.TW) Income Statement Analysis – Financial Results
Beijing Bohui Innovation Biotechnology Group Co., Ltd. (300318.SZ)
About Beijing Bohui Innovation Biotechnology Group Co., Ltd.
Beijing Bohui Innovation Biotechnology Group Co., Ltd. engages in the research and development, production, sale, and after-sale service of diagnostic products in China. It offers GenPlex, a microfluidic automated nucleic acid detection system, immunofluorescence detection products, and human trace element detection products; and chemical analysis products, such as atomic fluorescence spectrometer and photometer, mass spectrometers, chip ion sources, microfluidic flow chemical analysis systems, life sciences related consumables, and ICP spectroscopy. The company was formerly known as Beijing Bohui Innovation Biotechnology Co., Ltd. and changed its name to Beijing Bohui Innovation Biotechnology Group Co., Ltd. in August 2021. Beijing Bohui Innovation Biotechnology Group Co., Ltd. was founded in 2001 and is headquartered in Beijing, China.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 1.05B | 795.93M | 714.75M | 738.72M | 628.34M | 622.09M | 443.75M | 404.05M | 268.85M | 100.97M | 106.87M | 113.76M | 98.12M | 78.41M | 63.58M | 51.46M | 39.40M | 29.37M | 25.88M | 24.51M |
Cost of Revenue | 590.57M | 541.14M | 421.92M | 379.01M | 324.27M | 309.74M | 208.62M | 189.22M | 140.57M | 21.63M | 24.12M | 25.41M | 22.63M | 16.62M | 14.55M | 11.95M | 9.73M | 6.19M | 5.92M | 5.31M |
Gross Profit | 454.86M | 254.79M | 292.83M | 359.70M | 304.07M | 312.36M | 235.14M | 214.83M | 128.27M | 79.33M | 82.75M | 88.35M | 75.49M | 61.79M | 49.04M | 39.51M | 29.67M | 23.17M | 19.96M | 19.20M |
Gross Profit Ratio | 43.51% | 32.01% | 40.97% | 48.69% | 48.39% | 50.21% | 52.99% | 53.17% | 47.71% | 78.57% | 77.43% | 77.66% | 76.94% | 78.80% | 77.12% | 76.78% | 75.30% | 78.91% | 77.12% | 78.35% |
Research & Development | 69.20M | 64.78M | 81.48M | 48.18M | 46.58M | 53.46M | 48.51M | 40.54M | 35.52M | 21.36M | 11.89M | 11.24M | 8.33M | 7.21M | 5.22M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 77.67M | 40.65M | 71.47M | 41.73M | 26.21M | 25.29M | 21.43M | 10.60M | 16.12M | 5.21M | 3.28M | 4.02M | 1.96M | 2.03M | 2.30M | 10.45M | 6.02M | 5.14M | 4.06M | 3.95M |
Selling & Marketing | 37.21M | 116.24M | 134.39M | 137.85M | 120.04M | 123.51M | 81.96M | 59.49M | 35.71M | 20.88M | 16.32M | 15.06M | 11.63M | 11.01M | 9.51M | 7.84M | 5.96M | 4.70M | 3.56M | 3.63M |
SG&A | 114.88M | 156.89M | 205.86M | 179.59M | 146.26M | 148.80M | 103.39M | 70.09M | 51.83M | 26.08M | 19.61M | 19.07M | 13.59M | 13.04M | 11.81M | 18.30M | 11.98M | 9.84M | 7.61M | 7.58M |
Other Expenses | 236.97M | -6.15M | -1.87M | -2.79M | -1.54M | -659.27K | 551.96K | 6.23M | 3.86M | 3.75M | 4.46M | 2.28M | 1.69M | 1.49M | 1.35M | 1.43M | 4.41M | 1.34M | 1.72M | 2.43M |
Operating Expenses | 421.05M | 345.30M | 390.48M | 318.43M | 245.96M | 252.78M | 201.32M | 159.90M | 120.90M | 57.38M | 37.46M | 36.01M | 27.80M | 24.61M | 21.11M | 18.80M | 12.30M | 10.11M | 7.86M | 7.93M |
Cost & Expenses | 1.01B | 886.44M | 812.40M | 697.45M | 570.23M | 562.52M | 409.94M | 349.12M | 261.47M | 79.02M | 61.58M | 61.42M | 50.43M | 41.23M | 35.66M | 30.75M | 22.03M | 16.30M | 13.78M | 13.24M |
Interest Income | 3.28M | 512.37K | 350.66K | 2.09M | 229.03K | 182.41K | 148.65K | 1.67M | 4.73M | 6.67M | 13.22M | 3.69M | 1.89M | 627.18K | 1.18M | -0.77 | 0.00 | -0.90 | -0.43 | 0.00 |
Interest Expense | 27.62M | 42.25M | 45.06M | 35.44M | 43.43M | 34.02M | 26.73M | 7.46M | 67.39K | 6.66M | 13.11M | 22.05K | 27.15K | 19.82K | -110.00 | 88.48K | 0.00 | 548.23K | 172.13K | 0.00 |
Depreciation & Amortization | 123.40M | 119.39M | 113.94M | 99.02M | 83.71M | 78.13M | 58.17M | 43.88M | 29.20M | 7.87M | 5.49M | 5.63M | 5.04M | 1.59M | 1.61M | 1.57M | 1.46M | 757.64K | -1.26M | -828.60K |
EBITDA | 185.80M | 28.82M | -344.36M | 136.25M | 137.11M | 219.55M | 185.40M | 113.97M | 52.24M | 30.46M | 50.79M | 57.98M | 56.92M | 39.42M | 30.13M | 22.28M | 19.32M | 13.82M | 12.10M | 11.27M |
EBITDA Ratio | 17.77% | 1.41% | 1.66% | 17.96% | 20.54% | 76.82% | 21.58% | 24.27% | 16.59% | 30.17% | 48.02% | 51.21% | 53.75% | 50.28% | 47.39% | 43.72% | 47.79% | 47.06% | 46.76% | 45.99% |
Operating Income | 33.81M | -127.63M | -502.31M | 3.46M | 11.08M | 107.63M | 99.59M | 43.63M | 10.87M | 39.34M | 57.87M | 55.73M | 49.50M | 37.06M | 28.49M | 44.24M | 22.93M | 12.61M | 13.36M | 12.10M |
Operating Income Ratio | 3.23% | -16.04% | -70.28% | 0.47% | 1.76% | 17.30% | 22.44% | 10.80% | 4.04% | 38.96% | 54.15% | 48.99% | 50.45% | 47.27% | 44.81% | 85.96% | 58.21% | 42.95% | 51.63% | 49.38% |
Total Other Income/Expenses | -85.69K | -6.15M | -392.20M | -25.62M | -27.78M | -659.27K | 551.96K | 6.00M | 3.86M | 21.76M | 17.57M | 5.95M | 1.69M | 1.49M | 1.35M | 1.43M | 5.76M | 1.32M | 1.59M | 2.37M |
Income Before Tax | 33.73M | -133.78M | -504.18M | 585.01K | 9.63M | 106.97M | 100.14M | 49.63M | 14.74M | 43.09M | 62.32M | 58.01M | 51.19M | 38.56M | 29.84M | 45.67M | 26.11M | 13.94M | 14.95M | 14.48M |
Income Before Tax Ratio | 3.23% | -16.81% | -70.54% | 0.08% | 1.53% | 17.20% | 22.57% | 12.28% | 5.48% | 42.67% | 58.31% | 50.99% | 52.17% | 49.18% | 46.94% | 88.74% | 66.28% | 47.46% | 57.77% | 59.06% |
Income Tax Expense | 18.05M | 4.14M | 1.61M | 8.14M | 7.61M | 29.47M | 52.89M | 1.48M | -742.13K | 6.54M | 9.50M | 8.56M | 7.68M | 5.88M | 4.64M | 6.75M | 3.81M | 982.62K | 1.03M | 685.80K |
Net Income | -24.93M | -78.33M | -322.18M | 7.50M | 2.54M | 69.44M | 38.85M | 23.60M | 11.88M | 38.14M | 54.26M | 50.95M | 44.78M | 33.74M | 25.91M | 39.85M | 22.30M | 12.95M | 13.92M | 13.79M |
Net Income Ratio | -2.38% | -9.84% | -45.08% | 1.02% | 0.40% | 11.16% | 8.76% | 5.84% | 4.42% | 37.77% | 50.77% | 44.79% | 45.63% | 43.04% | 40.75% | 77.44% | 56.60% | 44.11% | 53.79% | 56.26% |
EPS | -0.03 | -0.10 | -0.39 | 0.01 | 0.00 | 0.08 | 0.05 | 0.03 | 0.03 | 0.05 | 0.08 | 0.14 | 0.09 | 0.07 | 0.05 | 0.08 | 0.08 | 0.04 | 0.07 | 0.07 |
EPS Diluted | -0.03 | -0.10 | -0.39 | 0.01 | 0.00 | 0.08 | 0.05 | 0.03 | 0.03 | 0.05 | 0.08 | 0.14 | 0.09 | 0.07 | 0.05 | 0.08 | 0.08 | 0.04 | 0.07 | 0.07 |
Weighted Avg Shares Out | 817.36M | 816.90M | 816.90M | 816.90M | 816.90M | 818.85M | 816.20M | 813.76M | 392.15M | 734.06M | 652.68M | 365.45M | 492.12M | 488.87M | 485.82M | 488.57M | 308.95M | 0.00 | 0.00 | 0.00 |
Weighted Avg Shares Out (Dil) | 817.36M | 816.90M | 816.90M | 816.90M | 816.90M | 818.85M | 816.20M | 816.58M | 392.15M | 734.06M | 652.68M | 365.45M | 492.12M | 488.87M | 485.82M | 488.57M | 308.95M | 0.00 | 0.00 | 0.00 |
Source: https://incomestatements.info
Category: Stock Reports